Henry Schein (NASDAQ:HSIC) Issues FY 2025 Earnings Guidance

Henry Schein (NASDAQ:HSIC) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.800-4.940 for the period, compared to the consensus EPS estimate of 4.970. The company issued revenue guidance of $12.4 billion-$13.2 billion, compared to the consensus revenue estimate of $13.2 billion. Henry Schein also updated its FY25 guidance to $4.80-4.94 EPS.

Henry Schein Stock Down 2.3 %

HSIC opened at $75.82 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.45 billion, a PE ratio of 31.20, a P/E/G ratio of 2.13 and a beta of 0.91. The stock’s fifty day moving average is $74.25 and its 200-day moving average is $72.43. Henry Schein has a one year low of $63.67 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter last year, the firm posted $0.66 earnings per share. Henry Schein’s revenue was up 5.8% compared to the same quarter last year. On average, equities analysts predict that Henry Schein will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent research reports. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research restated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday. Mizuho began coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Eight investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.